Cardlytics Inc. (CDLX)$0.69
Currency: USD
Research Snapshot
Static fundamentals, valuation context, and investor signals for Cardlytics Inc. (CDLX).
DCF ready
Valuation
22.8x
EV/FCF, 4.4% FCF yield
Quality
-50.5%
ROIC, 4.1% FCF margin
Growth
2.6%
5Y sales (revenue) CAGR
Balance sheet
-32.7x
Debt/equity, 1.8x current ratio
Superinvestors
1
Top: Clifford Sosin (0.3%)
Strengths to research
- Return on equity is strong at 1598.0%.
- Debt/equity looks manageable at -32.7x.
- 10 annual periods are available for trend analysis.
Watchouts
No major valuation, balance sheet, or growth watchouts were detected by the static screen.
Annual data: 10 periods
Quarterly data: 24 periods
Stock snapshot: May 25, 2026
Static dataset: May 25, 2026
Quality Scorecard
Build-time composite score for CDLX.
Grade F
12
/ 100
Financial Charts
No financial data available for CDLX (annual).
1 superinvestors own CDLX
Current quarter ownership and quarter-over-quarter share changes.
Superinvestor ownership
| Fund | Shares | Value | % Portfolio | QoQ Change |
|---|---|---|---|---|
| Clifford Sosin CAS Investment Partners | 5,198,067 | $5M | 0.31% | ▲ +3.1% |